The research team of Prof. Wanliang Lu developed a protease-cleavable liposome for co-delivery of anti-PD-L1 for colon cancer therapy

Journal of Chinese Pharmaceutical Sciences ›› 2025, Vol. 34 ›› Issue (4): 407-407.

The research team of Prof. Wanliang Lu developed a protease-cleavable liposome for co-delivery of anti-PD-L1 for colon cancer therapy

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2025-04-10 Revised:2025-04-10 Accepted:2025-04-10 Online:2025-05-02 Published:2025-05-02

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lu developed a protease-cleavable liposome for co-delivery of anti-PD-L1 for colon cancer therapy[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(4): 407-407.

The research team of Prof. Wanliang Lu developed a protease-cleavable liposome for co-delivery of anti-PD-L1 for colon cancer therapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments